Global Rotavirus Vaccine Market Growth 2026-2032
The global Rotavirus Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The rotavirus vaccine is a vaccine designed to protect against rotavirus, a highly contagious virus that is the leading cause of severe diarrhea and dehydration in infants and young children worldwide. There are two main types of rotavirus vaccines: the monovalent (covering a single strain) and the multivalent (covering multiple strains) versions. Both vaccines contain live, attenuated (weakened) strains of the virus and are administered orally in liquid form.
United States market for Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Rotavirus Vaccine players cover Merck, GlaxoSmithKline Biologicals, Lanzhou Institute of Biological Products, Bharat Biotech, Serum Institute of India, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Rotavirus Vaccine Industry Forecast” looks at past sales and reviews total world Rotavirus Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Rotavirus Vaccine sales for 2026 through 2032. With Rotavirus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rotavirus Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Rotavirus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rotavirus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rotavirus Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rotavirus Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rotavirus Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Rotavirus Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Rotavirus Vaccine market?
What factors are driving Rotavirus Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rotavirus Vaccine market opportunities vary by end market size?
How does Rotavirus Vaccine break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
The rotavirus vaccine is a vaccine designed to protect against rotavirus, a highly contagious virus that is the leading cause of severe diarrhea and dehydration in infants and young children worldwide. There are two main types of rotavirus vaccines: the monovalent (covering a single strain) and the multivalent (covering multiple strains) versions. Both vaccines contain live, attenuated (weakened) strains of the virus and are administered orally in liquid form.
United States market for Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Rotavirus Vaccine players cover Merck, GlaxoSmithKline Biologicals, Lanzhou Institute of Biological Products, Bharat Biotech, Serum Institute of India, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Rotavirus Vaccine Industry Forecast” looks at past sales and reviews total world Rotavirus Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Rotavirus Vaccine sales for 2026 through 2032. With Rotavirus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rotavirus Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Rotavirus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rotavirus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rotavirus Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rotavirus Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rotavirus Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Rotavirus Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Government Institution
- Private Sector
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- GlaxoSmithKline Biologicals
- Lanzhou Institute of Biological Products
- Bharat Biotech
- Serum Institute of India
What is the 10-year outlook for the global Rotavirus Vaccine market?
What factors are driving Rotavirus Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rotavirus Vaccine market opportunities vary by end market size?
How does Rotavirus Vaccine break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rotavirus Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Rotavirus Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Rotavirus Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Rotavirus Vaccine Segment by Type
2.2.1 Monovalent Vaccine
2.2.2 Multivalent Vaccine
2.2.3 Rotavirus Vaccine Sales by Type
2.2.3.1 Global Rotavirus Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Rotavirus Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Rotavirus Vaccine Sale Price by Type (2021-2026)
2.3 Rotavirus Vaccine Segment by Application
2.3.1 Government Institution
2.3.2 Private Sector
2.3.3 Other
2.3.4 Rotavirus Vaccine Sales by Application
2.3.4.1 Global Rotavirus Vaccine Sale Market Share by Application (2021-2026)
2.3.4.2 Global Rotavirus Vaccine Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Rotavirus Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Rotavirus Vaccine Breakdown Data by Company
3.1.1 Global Rotavirus Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Rotavirus Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Rotavirus Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Rotavirus Vaccine Revenue by Company (2021-2026)
3.2.2 Global Rotavirus Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Rotavirus Vaccine Sale Price by Company
3.4 Key Manufacturers Rotavirus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rotavirus Vaccine Product Location Distribution
3.4.2 Players Rotavirus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Rotavirus Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Rotavirus Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Rotavirus Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Rotavirus Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Rotavirus Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Rotavirus Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Rotavirus Vaccine Sales Growth
4.4 APAC Rotavirus Vaccine Sales Growth
4.5 Europe Rotavirus Vaccine Sales Growth
4.6 Middle East & Africa Rotavirus Vaccine Sales Growth
5 AMERICAS
5.1 Americas Rotavirus Vaccine Sales by Country
5.1.1 Americas Rotavirus Vaccine Sales by Country (2021-2026)
5.1.2 Americas Rotavirus Vaccine Revenue by Country (2021-2026)
5.2 Americas Rotavirus Vaccine Sales by Type (2021-2026)
5.3 Americas Rotavirus Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rotavirus Vaccine Sales by Region
6.1.1 APAC Rotavirus Vaccine Sales by Region (2021-2026)
6.1.2 APAC Rotavirus Vaccine Revenue by Region (2021-2026)
6.2 APAC Rotavirus Vaccine Sales by Type (2021-2026)
6.3 APAC Rotavirus Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rotavirus Vaccine by Country
7.1.1 Europe Rotavirus Vaccine Sales by Country (2021-2026)
7.1.2 Europe Rotavirus Vaccine Revenue by Country (2021-2026)
7.2 Europe Rotavirus Vaccine Sales by Type (2021-2026)
7.3 Europe Rotavirus Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rotavirus Vaccine by Country
8.1.1 Middle East & Africa Rotavirus Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Rotavirus Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Rotavirus Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Rotavirus Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rotavirus Vaccine
10.3 Manufacturing Process Analysis of Rotavirus Vaccine
10.4 Industry Chain Structure of Rotavirus Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rotavirus Vaccine Distributors
11.3 Rotavirus Vaccine Customer
12 WORLD FORECAST REVIEW FOR ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
12.1 Global Rotavirus Vaccine Market Size Forecast by Region
12.1.1 Global Rotavirus Vaccine Forecast by Region (2027-2032)
12.1.2 Global Rotavirus Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Rotavirus Vaccine Forecast by Type (2027-2032)
12.7 Global Rotavirus Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Rotavirus Vaccine Product Portfolios and Specifications
13.1.3 Merck Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GlaxoSmithKline Biologicals
13.2.1 GlaxoSmithKline Biologicals Company Information
13.2.2 GlaxoSmithKline Biologicals Rotavirus Vaccine Product Portfolios and Specifications
13.2.3 GlaxoSmithKline Biologicals Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GlaxoSmithKline Biologicals Main Business Overview
13.2.5 GlaxoSmithKline Biologicals Latest Developments
13.3 Lanzhou Institute of Biological Products
13.3.1 Lanzhou Institute of Biological Products Company Information
13.3.2 Lanzhou Institute of Biological Products Rotavirus Vaccine Product Portfolios and Specifications
13.3.3 Lanzhou Institute of Biological Products Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Lanzhou Institute of Biological Products Main Business Overview
13.3.5 Lanzhou Institute of Biological Products Latest Developments
13.4 Bharat Biotech
13.4.1 Bharat Biotech Company Information
13.4.2 Bharat Biotech Rotavirus Vaccine Product Portfolios and Specifications
13.4.3 Bharat Biotech Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bharat Biotech Main Business Overview
13.4.5 Bharat Biotech Latest Developments
13.5 Serum Institute of India
13.5.1 Serum Institute of India Company Information
13.5.2 Serum Institute of India Rotavirus Vaccine Product Portfolios and Specifications
13.5.3 Serum Institute of India Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Serum Institute of India Main Business Overview
13.5.5 Serum Institute of India Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rotavirus Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Rotavirus Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Rotavirus Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Rotavirus Vaccine Segment by Type
2.2.1 Monovalent Vaccine
2.2.2 Multivalent Vaccine
2.2.3 Rotavirus Vaccine Sales by Type
2.2.3.1 Global Rotavirus Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Rotavirus Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Rotavirus Vaccine Sale Price by Type (2021-2026)
2.3 Rotavirus Vaccine Segment by Application
2.3.1 Government Institution
2.3.2 Private Sector
2.3.3 Other
2.3.4 Rotavirus Vaccine Sales by Application
2.3.4.1 Global Rotavirus Vaccine Sale Market Share by Application (2021-2026)
2.3.4.2 Global Rotavirus Vaccine Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Rotavirus Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Rotavirus Vaccine Breakdown Data by Company
3.1.1 Global Rotavirus Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Rotavirus Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Rotavirus Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Rotavirus Vaccine Revenue by Company (2021-2026)
3.2.2 Global Rotavirus Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Rotavirus Vaccine Sale Price by Company
3.4 Key Manufacturers Rotavirus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rotavirus Vaccine Product Location Distribution
3.4.2 Players Rotavirus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Rotavirus Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Rotavirus Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Rotavirus Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Rotavirus Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Rotavirus Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Rotavirus Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Rotavirus Vaccine Sales Growth
4.4 APAC Rotavirus Vaccine Sales Growth
4.5 Europe Rotavirus Vaccine Sales Growth
4.6 Middle East & Africa Rotavirus Vaccine Sales Growth
5 AMERICAS
5.1 Americas Rotavirus Vaccine Sales by Country
5.1.1 Americas Rotavirus Vaccine Sales by Country (2021-2026)
5.1.2 Americas Rotavirus Vaccine Revenue by Country (2021-2026)
5.2 Americas Rotavirus Vaccine Sales by Type (2021-2026)
5.3 Americas Rotavirus Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rotavirus Vaccine Sales by Region
6.1.1 APAC Rotavirus Vaccine Sales by Region (2021-2026)
6.1.2 APAC Rotavirus Vaccine Revenue by Region (2021-2026)
6.2 APAC Rotavirus Vaccine Sales by Type (2021-2026)
6.3 APAC Rotavirus Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rotavirus Vaccine by Country
7.1.1 Europe Rotavirus Vaccine Sales by Country (2021-2026)
7.1.2 Europe Rotavirus Vaccine Revenue by Country (2021-2026)
7.2 Europe Rotavirus Vaccine Sales by Type (2021-2026)
7.3 Europe Rotavirus Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rotavirus Vaccine by Country
8.1.1 Middle East & Africa Rotavirus Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Rotavirus Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Rotavirus Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Rotavirus Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rotavirus Vaccine
10.3 Manufacturing Process Analysis of Rotavirus Vaccine
10.4 Industry Chain Structure of Rotavirus Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rotavirus Vaccine Distributors
11.3 Rotavirus Vaccine Customer
12 WORLD FORECAST REVIEW FOR ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
12.1 Global Rotavirus Vaccine Market Size Forecast by Region
12.1.1 Global Rotavirus Vaccine Forecast by Region (2027-2032)
12.1.2 Global Rotavirus Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Rotavirus Vaccine Forecast by Type (2027-2032)
12.7 Global Rotavirus Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Rotavirus Vaccine Product Portfolios and Specifications
13.1.3 Merck Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GlaxoSmithKline Biologicals
13.2.1 GlaxoSmithKline Biologicals Company Information
13.2.2 GlaxoSmithKline Biologicals Rotavirus Vaccine Product Portfolios and Specifications
13.2.3 GlaxoSmithKline Biologicals Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GlaxoSmithKline Biologicals Main Business Overview
13.2.5 GlaxoSmithKline Biologicals Latest Developments
13.3 Lanzhou Institute of Biological Products
13.3.1 Lanzhou Institute of Biological Products Company Information
13.3.2 Lanzhou Institute of Biological Products Rotavirus Vaccine Product Portfolios and Specifications
13.3.3 Lanzhou Institute of Biological Products Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Lanzhou Institute of Biological Products Main Business Overview
13.3.5 Lanzhou Institute of Biological Products Latest Developments
13.4 Bharat Biotech
13.4.1 Bharat Biotech Company Information
13.4.2 Bharat Biotech Rotavirus Vaccine Product Portfolios and Specifications
13.4.3 Bharat Biotech Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bharat Biotech Main Business Overview
13.4.5 Bharat Biotech Latest Developments
13.5 Serum Institute of India
13.5.1 Serum Institute of India Company Information
13.5.2 Serum Institute of India Rotavirus Vaccine Product Portfolios and Specifications
13.5.3 Serum Institute of India Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Serum Institute of India Main Business Overview
13.5.5 Serum Institute of India Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Rotavirus Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Rotavirus Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monovalent Vaccine
Table 4. Major Players of Multivalent Vaccine
Table 5. Global Rotavirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Rotavirus Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Rotavirus Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Rotavirus Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Rotavirus Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Rotavirus Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Rotavirus Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Rotavirus Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Rotavirus Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Rotavirus Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Rotavirus Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Rotavirus Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Rotavirus Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Rotavirus Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Rotavirus Vaccine Producing Area Distribution and Sales Area
Table 21. Players Rotavirus Vaccine Products Offered
Table 22. Rotavirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Rotavirus Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Rotavirus Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Rotavirus Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Rotavirus Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Rotavirus Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Rotavirus Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Rotavirus Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Rotavirus Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Rotavirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Rotavirus Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Rotavirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Rotavirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Rotavirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Rotavirus Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Rotavirus Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Rotavirus Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Rotavirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Rotavirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Rotavirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Rotavirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Rotavirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Rotavirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Rotavirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Rotavirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Rotavirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Rotavirus Vaccine
Table 52. Key Market Challenges & Risks of Rotavirus Vaccine
Table 53. Key Industry Trends of Rotavirus Vaccine
Table 54. Rotavirus Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Rotavirus Vaccine Distributors List
Table 57. Rotavirus Vaccine Customer List
Table 58. Global Rotavirus Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Rotavirus Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Rotavirus Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Rotavirus Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Rotavirus Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Rotavirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Rotavirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Rotavirus Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Rotavirus Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Rotavirus Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Rotavirus Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Merck Basic Information, Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Rotavirus Vaccine Product Portfolios and Specifications
Table 74. Merck Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. GlaxoSmithKline Biologicals Basic Information, Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. GlaxoSmithKline Biologicals Rotavirus Vaccine Product Portfolios and Specifications
Table 79. GlaxoSmithKline Biologicals Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. GlaxoSmithKline Biologicals Main Business
Table 81. GlaxoSmithKline Biologicals Latest Developments
Table 82. Lanzhou Institute of Biological Products Basic Information, Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Lanzhou Institute of Biological Products Rotavirus Vaccine Product Portfolios and Specifications
Table 84. Lanzhou Institute of Biological Products Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Lanzhou Institute of Biological Products Main Business
Table 86. Lanzhou Institute of Biological Products Latest Developments
Table 87. Bharat Biotech Basic Information, Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Bharat Biotech Rotavirus Vaccine Product Portfolios and Specifications
Table 89. Bharat Biotech Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Bharat Biotech Main Business
Table 91. Bharat Biotech Latest Developments
Table 92. Serum Institute of India Basic Information, Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Serum Institute of India Rotavirus Vaccine Product Portfolios and Specifications
Table 94. Serum Institute of India Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Serum Institute of India Main Business
Table 96. Serum Institute of India Latest Developments
Table 1. Rotavirus Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Rotavirus Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monovalent Vaccine
Table 4. Major Players of Multivalent Vaccine
Table 5. Global Rotavirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Rotavirus Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Rotavirus Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Rotavirus Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Rotavirus Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Rotavirus Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Rotavirus Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Rotavirus Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Rotavirus Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Rotavirus Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Rotavirus Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Rotavirus Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Rotavirus Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Rotavirus Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Rotavirus Vaccine Producing Area Distribution and Sales Area
Table 21. Players Rotavirus Vaccine Products Offered
Table 22. Rotavirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Rotavirus Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Rotavirus Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Rotavirus Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Rotavirus Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Rotavirus Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Rotavirus Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Rotavirus Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Rotavirus Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Rotavirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Rotavirus Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Rotavirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Rotavirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Rotavirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Rotavirus Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Rotavirus Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Rotavirus Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Rotavirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Rotavirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Rotavirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Rotavirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Rotavirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Rotavirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Rotavirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Rotavirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Rotavirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Rotavirus Vaccine
Table 52. Key Market Challenges & Risks of Rotavirus Vaccine
Table 53. Key Industry Trends of Rotavirus Vaccine
Table 54. Rotavirus Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Rotavirus Vaccine Distributors List
Table 57. Rotavirus Vaccine Customer List
Table 58. Global Rotavirus Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Rotavirus Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Rotavirus Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Rotavirus Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Rotavirus Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Rotavirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Rotavirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Rotavirus Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Rotavirus Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Rotavirus Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Rotavirus Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Merck Basic Information, Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Rotavirus Vaccine Product Portfolios and Specifications
Table 74. Merck Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. GlaxoSmithKline Biologicals Basic Information, Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. GlaxoSmithKline Biologicals Rotavirus Vaccine Product Portfolios and Specifications
Table 79. GlaxoSmithKline Biologicals Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. GlaxoSmithKline Biologicals Main Business
Table 81. GlaxoSmithKline Biologicals Latest Developments
Table 82. Lanzhou Institute of Biological Products Basic Information, Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Lanzhou Institute of Biological Products Rotavirus Vaccine Product Portfolios and Specifications
Table 84. Lanzhou Institute of Biological Products Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Lanzhou Institute of Biological Products Main Business
Table 86. Lanzhou Institute of Biological Products Latest Developments
Table 87. Bharat Biotech Basic Information, Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Bharat Biotech Rotavirus Vaccine Product Portfolios and Specifications
Table 89. Bharat Biotech Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Bharat Biotech Main Business
Table 91. Bharat Biotech Latest Developments
Table 92. Serum Institute of India Basic Information, Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Serum Institute of India Rotavirus Vaccine Product Portfolios and Specifications
Table 94. Serum Institute of India Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Serum Institute of India Main Business
Table 96. Serum Institute of India Latest Developments
LIST OF FIGURES
Figure 1. Picture of Rotavirus Vaccine
Figure 2. Rotavirus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rotavirus Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Rotavirus Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Rotavirus Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Rotavirus Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Rotavirus Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Monovalent Vaccine
Figure 12. Product Picture of Multivalent Vaccine
Figure 13. Global Rotavirus Vaccine Sales Market Share by Type in 2026
Figure 14. Global Rotavirus Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Rotavirus Vaccine Consumed in Government Institution
Figure 16. Global Rotavirus Vaccine Market: Government Institution (2021-2026) & (K Units)
Figure 17. Rotavirus Vaccine Consumed in Private Sector
Figure 18. Global Rotavirus Vaccine Market: Private Sector (2021-2026) & (K Units)
Figure 19. Rotavirus Vaccine Consumed in Other
Figure 20. Global Rotavirus Vaccine Market: Other (2021-2026) & (K Units)
Figure 21. Global Rotavirus Vaccine Sale Market Share by Application (2025)
Figure 22. Global Rotavirus Vaccine Revenue Market Share by Application in 2026
Figure 23. Rotavirus Vaccine Sales by Company in 2026 (K Units)
Figure 24. Global Rotavirus Vaccine Sales Market Share by Company in 2026
Figure 25. Rotavirus Vaccine Revenue by Company in 2026 ($ millions)
Figure 26. Global Rotavirus Vaccine Revenue Market Share by Company in 2026
Figure 27. Global Rotavirus Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Rotavirus Vaccine Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Rotavirus Vaccine Sales 2021-2026 (K Units)
Figure 30. Americas Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 31. APAC Rotavirus Vaccine Sales 2021-2026 (K Units)
Figure 32. APAC Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Europe Rotavirus Vaccine Sales 2021-2026 (K Units)
Figure 34. Europe Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Rotavirus Vaccine Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 37. Americas Rotavirus Vaccine Sales Market Share by Country in 2026
Figure 38. Americas Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 39. Americas Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 40. Americas Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 41. United States Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Rotavirus Vaccine Sales Market Share by Region in 2026
Figure 46. APAC Rotavirus Vaccine Revenue Market Share by Region (2021-2026)
Figure 47. APAC Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 48. APAC Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 49. China Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. India Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Rotavirus Vaccine Sales Market Share by Country in 2026
Figure 57. Europe Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 58. Europe Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 59. Europe Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 60. Germany Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. France Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Rotavirus Vaccine Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 68. Egypt Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Rotavirus Vaccine in 2026
Figure 74. Manufacturing Process Analysis of Rotavirus Vaccine
Figure 75. Industry Chain Structure of Rotavirus Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Rotavirus Vaccine Sales Market Forecast by Region (2027-2032)
Figure 78. Global Rotavirus Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Rotavirus Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Rotavirus Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Rotavirus Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Rotavirus Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Rotavirus Vaccine
Figure 2. Rotavirus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rotavirus Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Rotavirus Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Rotavirus Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Rotavirus Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Rotavirus Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Monovalent Vaccine
Figure 12. Product Picture of Multivalent Vaccine
Figure 13. Global Rotavirus Vaccine Sales Market Share by Type in 2026
Figure 14. Global Rotavirus Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Rotavirus Vaccine Consumed in Government Institution
Figure 16. Global Rotavirus Vaccine Market: Government Institution (2021-2026) & (K Units)
Figure 17. Rotavirus Vaccine Consumed in Private Sector
Figure 18. Global Rotavirus Vaccine Market: Private Sector (2021-2026) & (K Units)
Figure 19. Rotavirus Vaccine Consumed in Other
Figure 20. Global Rotavirus Vaccine Market: Other (2021-2026) & (K Units)
Figure 21. Global Rotavirus Vaccine Sale Market Share by Application (2025)
Figure 22. Global Rotavirus Vaccine Revenue Market Share by Application in 2026
Figure 23. Rotavirus Vaccine Sales by Company in 2026 (K Units)
Figure 24. Global Rotavirus Vaccine Sales Market Share by Company in 2026
Figure 25. Rotavirus Vaccine Revenue by Company in 2026 ($ millions)
Figure 26. Global Rotavirus Vaccine Revenue Market Share by Company in 2026
Figure 27. Global Rotavirus Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Rotavirus Vaccine Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Rotavirus Vaccine Sales 2021-2026 (K Units)
Figure 30. Americas Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 31. APAC Rotavirus Vaccine Sales 2021-2026 (K Units)
Figure 32. APAC Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Europe Rotavirus Vaccine Sales 2021-2026 (K Units)
Figure 34. Europe Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Rotavirus Vaccine Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 37. Americas Rotavirus Vaccine Sales Market Share by Country in 2026
Figure 38. Americas Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 39. Americas Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 40. Americas Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 41. United States Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Rotavirus Vaccine Sales Market Share by Region in 2026
Figure 46. APAC Rotavirus Vaccine Revenue Market Share by Region (2021-2026)
Figure 47. APAC Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 48. APAC Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 49. China Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. India Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Rotavirus Vaccine Sales Market Share by Country in 2026
Figure 57. Europe Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 58. Europe Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 59. Europe Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 60. Germany Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. France Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Rotavirus Vaccine Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 68. Egypt Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Rotavirus Vaccine in 2026
Figure 74. Manufacturing Process Analysis of Rotavirus Vaccine
Figure 75. Industry Chain Structure of Rotavirus Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Rotavirus Vaccine Sales Market Forecast by Region (2027-2032)
Figure 78. Global Rotavirus Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Rotavirus Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Rotavirus Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Rotavirus Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Rotavirus Vaccine Revenue Market Share Forecast by Application (2027-2032)
